Browse by Person

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 1.


Kater, AP, Seymour, JF, Hillmen, P et al. (12 more authors) (2019) Fixed Duration of Venetoclax-Rituximab in Relapsed/Refractory Chronic Lymphocytic Leukemia Eradicates Minimal Residual Disease and Prolongs Survival: Post-Treatment Follow-Up of the MURANO Phase III Study. Journal of Clinical Oncology, 34 (4). pp. 269-277. ISSN 0732-183X

This list was generated on Sun Jul 5 08:41:05 2020 BST.